Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge

Julia Sarkadi, David Kuti, Mate Jankovics, E. Pállinger, Kinga Fodor, Zoltan Kis, E. Gönczöl, Ildiko Visontai, Istvan Jankovics

Research output: Article

1 Citation (Scopus)

Abstract

To investigate the protective efficacy of a seasonal trivalent inactivated whole virion influenza vaccine (TIV) adjuvanted with aluminum phosphate (Fluval AB, referred to here as TIV+Al), we immunized mice with the TIV+Al, and as controls, with TIV, TIV+Al combined with Freund adjuvant (TIV+Al+F), inactivated A/PR/8/34(H1N1) (PR8) strain or PBS, and challenged them with a lethal dose of a mouse-adapted PR8 virus. Serum pools from immunized mice were passively transferred to recipient mice that were then challenged similarly. All actively immunized mice survived the challenge. Of recipient mice receiving serum from mice actively immunized with TIV, TIV+Al or TIV+Al+F, 20%, 80%, and 100% survived, respectively. Rates of mortality and morbidity of recipient mice were inversely proportional to the hemagglutination inhibition (HI) antibody level to the vaccine virus in the absence of detectable PR8-specific HI, neuraminidase inhibition (NI) and virus neutralization (VN) antibodies. No cross-reactivity was observed between vaccine and PR8 strains in in vitro HI, NI or VN assays. In splenocytes from TIV+Al-immunized mice production of IFN-? or granzyme-B protein and mRNA expression increased (p<0.05). Thus, antibodies play a major role in the protection against a mismatched challenge infection independent of HI, NI and VN activity, but cellular immune responses may contribute to full protection in actively immunized mice.

Original languageEnglish
Pages (from-to)180-189
Number of pages10
JournalNew Microbiologica
Volume40
Issue number3
Publication statusPublished - júl. 1 2017

Fingerprint

Orthomyxoviridae
Viruses
Hemagglutination
Neuraminidase
Antibodies
Vaccines
Granzymes
Freund's Adjuvant
Influenza Vaccines
Serum
Cellular Immunity
Virion
Morbidity
Messenger RNA
Mortality
Infection

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Sarkadi, J., Kuti, D., Jankovics, M., Pállinger, E., Fodor, K., Kis, Z., ... Jankovics, I. (2017). Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge. New Microbiologica, 40(3), 180-189.

Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge. / Sarkadi, Julia; Kuti, David; Jankovics, Mate; Pállinger, E.; Fodor, Kinga; Kis, Zoltan; Gönczöl, E.; Visontai, Ildiko; Jankovics, Istvan.

In: New Microbiologica, Vol. 40, No. 3, 01.07.2017, p. 180-189.

Research output: Article

Sarkadi, J, Kuti, D, Jankovics, M, Pállinger, E, Fodor, K, Kis, Z, Gönczöl, E, Visontai, I & Jankovics, I 2017, 'Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge', New Microbiologica, vol. 40, no. 3, pp. 180-189.
Sarkadi, Julia ; Kuti, David ; Jankovics, Mate ; Pállinger, E. ; Fodor, Kinga ; Kis, Zoltan ; Gönczöl, E. ; Visontai, Ildiko ; Jankovics, Istvan. / Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge. In: New Microbiologica. 2017 ; Vol. 40, No. 3. pp. 180-189.
@article{6c2c40833255419283a418797ddd574d,
title = "Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge",
abstract = "To investigate the protective efficacy of a seasonal trivalent inactivated whole virion influenza vaccine (TIV) adjuvanted with aluminum phosphate (Fluval AB, referred to here as TIV+Al), we immunized mice with the TIV+Al, and as controls, with TIV, TIV+Al combined with Freund adjuvant (TIV+Al+F), inactivated A/PR/8/34(H1N1) (PR8) strain or PBS, and challenged them with a lethal dose of a mouse-adapted PR8 virus. Serum pools from immunized mice were passively transferred to recipient mice that were then challenged similarly. All actively immunized mice survived the challenge. Of recipient mice receiving serum from mice actively immunized with TIV, TIV+Al or TIV+Al+F, 20{\%}, 80{\%}, and 100{\%} survived, respectively. Rates of mortality and morbidity of recipient mice were inversely proportional to the hemagglutination inhibition (HI) antibody level to the vaccine virus in the absence of detectable PR8-specific HI, neuraminidase inhibition (NI) and virus neutralization (VN) antibodies. No cross-reactivity was observed between vaccine and PR8 strains in in vitro HI, NI or VN assays. In splenocytes from TIV+Al-immunized mice production of IFN-? or granzyme-B protein and mRNA expression increased (p<0.05). Thus, antibodies play a major role in the protection against a mismatched challenge infection independent of HI, NI and VN activity, but cellular immune responses may contribute to full protection in actively immunized mice.",
keywords = "Cellular immunity, Challenge infection, Influenza vaccine, Protection, Serum transfer",
author = "Julia Sarkadi and David Kuti and Mate Jankovics and E. P{\'a}llinger and Kinga Fodor and Zoltan Kis and E. G{\"o}ncz{\"o}l and Ildiko Visontai and Istvan Jankovics",
year = "2017",
month = "7",
day = "1",
language = "English",
volume = "40",
pages = "180--189",
journal = "New Microbiologica",
issn = "1121-7138",
publisher = "Luigi Ponzio e figlio Editori",
number = "3",

}

TY - JOUR

T1 - Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge

AU - Sarkadi, Julia

AU - Kuti, David

AU - Jankovics, Mate

AU - Pállinger, E.

AU - Fodor, Kinga

AU - Kis, Zoltan

AU - Gönczöl, E.

AU - Visontai, Ildiko

AU - Jankovics, Istvan

PY - 2017/7/1

Y1 - 2017/7/1

N2 - To investigate the protective efficacy of a seasonal trivalent inactivated whole virion influenza vaccine (TIV) adjuvanted with aluminum phosphate (Fluval AB, referred to here as TIV+Al), we immunized mice with the TIV+Al, and as controls, with TIV, TIV+Al combined with Freund adjuvant (TIV+Al+F), inactivated A/PR/8/34(H1N1) (PR8) strain or PBS, and challenged them with a lethal dose of a mouse-adapted PR8 virus. Serum pools from immunized mice were passively transferred to recipient mice that were then challenged similarly. All actively immunized mice survived the challenge. Of recipient mice receiving serum from mice actively immunized with TIV, TIV+Al or TIV+Al+F, 20%, 80%, and 100% survived, respectively. Rates of mortality and morbidity of recipient mice were inversely proportional to the hemagglutination inhibition (HI) antibody level to the vaccine virus in the absence of detectable PR8-specific HI, neuraminidase inhibition (NI) and virus neutralization (VN) antibodies. No cross-reactivity was observed between vaccine and PR8 strains in in vitro HI, NI or VN assays. In splenocytes from TIV+Al-immunized mice production of IFN-? or granzyme-B protein and mRNA expression increased (p<0.05). Thus, antibodies play a major role in the protection against a mismatched challenge infection independent of HI, NI and VN activity, but cellular immune responses may contribute to full protection in actively immunized mice.

AB - To investigate the protective efficacy of a seasonal trivalent inactivated whole virion influenza vaccine (TIV) adjuvanted with aluminum phosphate (Fluval AB, referred to here as TIV+Al), we immunized mice with the TIV+Al, and as controls, with TIV, TIV+Al combined with Freund adjuvant (TIV+Al+F), inactivated A/PR/8/34(H1N1) (PR8) strain or PBS, and challenged them with a lethal dose of a mouse-adapted PR8 virus. Serum pools from immunized mice were passively transferred to recipient mice that were then challenged similarly. All actively immunized mice survived the challenge. Of recipient mice receiving serum from mice actively immunized with TIV, TIV+Al or TIV+Al+F, 20%, 80%, and 100% survived, respectively. Rates of mortality and morbidity of recipient mice were inversely proportional to the hemagglutination inhibition (HI) antibody level to the vaccine virus in the absence of detectable PR8-specific HI, neuraminidase inhibition (NI) and virus neutralization (VN) antibodies. No cross-reactivity was observed between vaccine and PR8 strains in in vitro HI, NI or VN assays. In splenocytes from TIV+Al-immunized mice production of IFN-? or granzyme-B protein and mRNA expression increased (p<0.05). Thus, antibodies play a major role in the protection against a mismatched challenge infection independent of HI, NI and VN activity, but cellular immune responses may contribute to full protection in actively immunized mice.

KW - Cellular immunity

KW - Challenge infection

KW - Influenza vaccine

KW - Protection

KW - Serum transfer

UR - http://www.scopus.com/inward/record.url?scp=85029785941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029785941&partnerID=8YFLogxK

M3 - Article

C2 - 28675247

AN - SCOPUS:85029785941

VL - 40

SP - 180

EP - 189

JO - New Microbiologica

JF - New Microbiologica

SN - 1121-7138

IS - 3

ER -